Literature DB >> 8198715

Altered biosynthesis of tumour necrosis factor (TNF) alpha is involved in postburn hypertrophic scars.

D Peruccio1, C Castagnoli, M Stella, S D'Alfonso, P R Momigliano, G Magliacani, S T Alasia.   

Abstract

The present study shows that the decrease of TNF alpha in postburn hypertrophic scars is due to a decrease in the steady-state level of TNF alpha mRNA and thus to an altered biosynthesis of the cytokine. Thirteen scars, including seven hypertrophic and six normotrophic scars, were tested for TNF alpha mRNA production by a semiquantitative reverse polymerase chain reaction (PCR) method. TNF beta and beta actin were tested as a control. Six out of six normotrophic scar samples amplified with primers for TNF alpha showed a positive PCR signal up to the 1:32 dilution. On the contrary all the hypertrophic tested samples (7/7) had a positive PCR signal only at the 1:1 or 1:2 dilution. All samples, both normotrophic and hypertrophic, were homogeneous as to TNF beta production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198715     DOI: 10.1016/s0305-4179(06)80007-0

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  4 in total

Review 1.  New molecular medicine-based scar management strategies.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-01-15       Impact factor: 2.744

2.  Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.

Authors:  Y P Han; T L Tuan; M Hughes; H Wu; W L Garner
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

3.  Increased sensitivity to TNF-α promotes keloid fibroblast hyperproliferation by activating the NF-κB, JNK and p38 MAPK pathways.

Authors:  Qijie Li; Fengrui Cheng; Kai Zhou; Lu Fang; Junliang Wu; Qingjie Xia; Ying Cen; Junjie Chen; Yong Qing
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

Review 4.  The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes.

Authors:  Sara Amjadian; Sharif Moradi; Parvaneh Mohammadi
Journal:  Skin Pharmacol Physiol       Date:  2022-06-13       Impact factor: 3.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.